# Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

> **NCT01328184** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** levonorgestrel
- **DRUG:** levonorgestrel
- **DRUG:** Ethinylestradiol
- **DRUG:** Microgynon + BI 10773
- **DRUG:** Ethinylestradiol

## Key facts

- **NCT ID:** NCT01328184
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-07
- **Final completion:** —
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328184, "Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01328184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*